Premium
Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D‐1 and D‐2 dopamine agonists in rat globus pallidus
Author(s) -
Carlson Joanne H.,
Bergstrom Debra A.,
Demo Susan D.,
Walters Judith R.
Publication year - 1990
Publication title -
synapse
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.809
H-Index - 106
eISSN - 1098-2396
pISSN - 0887-4476
DOI - 10.1002/syn.890050202
Subject(s) - quinpirole , apomorphine , agonist , globus pallidus , endocrinology , nigrostriatal pathway , medicine , chemistry , dopamine agonist , antagonist , dopamine antagonist , dopamine , oxidopamine , dopamine receptor , dopaminergic , haloperidol , basal ganglia , central nervous system , substantia nigra , receptor
The effects of the selective D‐1 dopamine agonist SKF 38893, the selective D‐2 agonist quinpirole, and the nonselective D‐1/D‐2 agonist apomorphine on spontaneous activity of globus pallidus neurons were compared in normal control rats and rats with unilateral 6‐hydroxydopamine induced lesions of the nigrostriatal pathway. In control, unlesioned rats, SKF 38393 (0.4 and 10 mg/kg, i.v.) caused no significant net change in the activity of globus pallidus neurons, although some individual cells showed significant increases of decreases in discharge rates following 10 mg/kg SKF 38393 administration. In animals with unilateral 6‐hydroxydopamine induced lesions, SKF 38393 caused greater increases and decreases in the discharge reates of a larger percentage of pallidal cells recorded on the ipsilateral side than in control, unlesioned animals. These rate changes were effectively reversed by the D‐1 antagonist SCH 23390, but not by the D‐2 antagonist YM‐09151–2. Quinpirole (0.3 mg/kg, i.v.) produced modest rate increases in control, unlesioned animals and significantly larger rate increases in nigrostriatal lesioned animals. YM‐09151–2, but not SCH 23390, effectively reversed quinpirole's effects in the lesioned animals. As previously reported, the nonselective D‐1/D‐2 agonist apomorphine (0.3 mg/kg, i.v.) produced large increases in discharge rates of pallidal cells in control, unlesioned rats. In contrast, in nigrostriatal lesioned rats, the discharge rates of some ipsilateral pallidal neurons were markedly increased, others were decreased, and some were unaffected following apomorphine administration. The dopamine antagonist spiroperidol partially to fully reversed these rate changes. In summary, apomorphine's neurophysiological profile appears to be an exaggeration of the D‐1 agonist profile in the globus pallidus of these lesioned animals. The degree of change observed after apomorphine administration is consistent with results from other studies that have indicated that a synergistic interaction between effects triggered by stimulation of the two receptor subtypes can occur in these animals, as in control, unlesioned animals. However, these results further show that in rats with unilateral nigrostriatal lesions, the denervated dopamine receptors or the processes they mediate are altered so that they no longer have the requirement seen in controls for concurrent stimulation of the complementary dopamine receptor subtype for expression of the selective agonist effects.